Thus, in the following experiments, the combined information from histological and immunohistochemical staining for neurons (NeuN) and the microtubule-associated protein 2 (MAP2) [34,35] was used to define the border of the stroke-affected area, which were chosen for the MELC analysis (Figure 2D). This evidence concerns the gene MAP2 and stroke disorder.